Peringkat dalam Saham
#42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Harga Saham
$0.0001
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$1.17K
Perubahan (1 tahun)
0.00%
Perdagangan PhaseRx, Inc. (PZRXQ)
Harga PZRXQ dengan kapitalisasi pasar B
Kapitalisasi pasar dari PhaseRx, Inc.(PZRXQ)
Kapitalisasi Pasar: $1.17K
Per August 2026, PhaseRx, Inc. memiliki kapitalisasi pasar sebesar $1.17K. Ini menjadikan PhaseRx, Inc. sebagai perusahaan 42474th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar PhaseRx, Inc. dari 2016 hingga 2026
PZRXQ dibandingkan dengan 5 teratas stocks paling populer
| Harga PZRXQ |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.426T
|
+464,168,840,447.48%
|
|
|
|
|
$4.426T
|
+378,617,171,037.73%
|
|
|
|
|
$4.159T
|
+355,751,159,202.91%
|
|
|
|
|
$3.663T
|
+313,308,663,886.31%
|
|
|
|
|
$2.892T
|
+247,381,085,150.73%
|
